Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study

By afschroeder • April 18, 2026

Mysler E, Sidiropoulos PI, Balanescu A, Detert J, Xavier RM, Charles-Schoeman C, Bessette L, Crowley A, Kaneko Y, Zhang Z, Nagy O, Liu Y, Ren J, Romero AB, Suboticki JL, DeMasi R, Meerwein S, Fleischmann R; SELECT-SWITCH Study Investigators. Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study. Ann Rheum Dis. 2026 Apr 15:S0003-4967(26)00198-6. doi: 10.1016/j.ard.2026.03.013. Epub ahead of print. PMID: 41991443.

Tags: Publications, Rheumatology

Biodegradable devices for transcatheter patent foramen ovale closure: current evidence and future directions

Khan A, Khan M, Thyagaturu H, Shafi N, Muhibullah F, Kanwal K, Irshad K, Fonarow GC, Sattar Y. Biodegradable devices for transcatheter patent foramen ovale[...]

Oncofertility patterns after the overturn of Roe v. Wade

Baclig NV, Silverstein J, Shah V, Karlan B, Anand SR, Glaspy JA. Oncofertility patterns after the overturn of Roe v. Wade. J Natl Cancer Inst.[...]

Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial

Lee GJ, Morrell HER, Adams M, Sabaté J, Reboussin DM, Kris-Etherton PM, Petersen KS, Lichtenstein AH, Matthan NR, Li Z, Rajaram S. Effects of one[...]